Abbott Laboratories plans to spend US$19.3 billion to buy St Jude Medical Inc in a cash-stock deal that aims to strengthen the medical device maker’s stake in cardiovascular care.
The combined company would offer devices in nearly every area of cardiovascular care, competing directly with industry leaders Medtronic Inc and Boston Scientific Corp.
It said the acquisition would blend St Jude’s pacemaker and implantable defibrillator business with Abbott’s focus on artery-opening stents and heart-repair products.
Wells Fargo analyst Larry Biegelsen said the deal makes sense because “there is very little overlap” between the companies’ offerings. The combined business would be better able to compete with larger companies in the device space, including Johnson & Johnson.
North Chicago, Illinois-based Abbott said St Jude shareholders would receive US$46.75 in cash and a portion of Abbott stock for each St Jude share. The total consideration adds up to about US$85 per share.
That represents a 37 percent premium to Wednesday’s US$61.95 closing price of St Jude shares.
The deal value totals US$25 billion based on Abbott’s recent stock price and assuming about US$5.7 billion in St Jude debt.
Abbott makes medical devices and generic drugs, but infant formula and nutritional beverages, which includes the Similac, Ensure and Pedialyte brands, make up the company’s biggest business.
In February, Abbott said it would spend US$4.8 billion on Alere Inc to expand its medical testing business.
St Jude’s expertise selling medical implants to hospitals should open new opportunities and help drive sales for Abbott’s devices, Leerink Swann analyst Danielle Antalffy said.
“Abbott’s device business has been underscaled, driving underperformance over the last few years,” Antalffy said in a note to investors.
Abbott said the boards of both companies had approved the deal for St Paul, Minnesota-based St Jude.
The companies expect the deal to close in the fourth quarter, but the acquisition must still be reviewed by regulators and approved by St Jude shareholders.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last